| Literature DB >> 18304310 |
Elizabeth Hughes1, Shamil Wanigaratne, Kevin Gournay, Sonia Johnson, Graham Thornicroft, Emily Finch, Jane Marshall, Neil Smith.
Abstract
BACKGROUND: Despite the high prevalence of co-morbid substance use among mental health service users (dual diagnosis), very few mental health workers in the UK have had training and/or clinical experience to equip them to deliver targeted interventions to this client group.Entities:
Mesh:
Year: 2008 PMID: 18304310 PMCID: PMC2277384 DOI: 10.1186/1471-244X-8-12
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Trainee Demographics
| Age years: | 37 (7.3) | 37 (6.2) |
| Number female, | 20 (53) | 19 (51) |
| Number White, | 21 (58) | 26 (78) |
| Number mental health nurse, | 22 (58) | 18 (49) |
| Number > 5 years in current profession, | 22 (59) | 25 (69) |
| Number attended study days relevant to dual diagnosis | 24 (63) | 25 (68) |
| Number never worked clinically in substance use services | 17 (45) | 20 (57) |
Figure 1CONSORT Diagram for Case Managers.
Primary Outcome Measures (AAPPQ) Baseline & Follow-up Means.
| 123.39 (19.69) | 131.15 (16.1) | 113.73 (18.33) | 116.56 (21.01) | 7.43 (-0.86 to 15.72) | 0.078 | |
| 114.75 (20.85) | 123.08 (16.64) | 107.97 (20.21) | 113.62 (20.45) | 4.27 (-3.09 to 11.64) | 0.250 | |
| 25.49 (4.25) | 26.03 (3.15) | 24.46 (4.90) | 23.21 (6.08) | 1.93 (-0.37 to 4.24) | 0.099 | |
| 24.32 (4.49) | 25.12 (3.60) | 23.40 (5.65) | 22.78 (5.78) | 1.32 (-0.37 to 4.24) | 0.209 | |
| 23.37 (4.35) | 23.25 (3.70) | 20.71 (3.86) | 20.62 (5.72) | 0.37 (-1.56 to 3.00) | 0.702 | |
| 21.66 (4.49) | 21.43 (3.87) | 19.85 (4.58) | 20.17 (5.81) | 0.09 (-2.12 to 1.93) | 0.926 | |
| 26.89 (7.08) | 31.71 (4.45) | 23.60 (7.16) | 26.29 (6.88) | 3.60 (1.03 to 6.16) | 0.007 | |
| 23.68 (6.98) | 28.91 (5.67) | 21.80 (7.28) | 25.00 (6.68) | 2.37 (-0.05 to 4.80) | 0.055 | |
| 19.39 (3.68) | 20.09 (4.33) | 19.12 (2.95) | 20.69 (2.93) | -0.75 (-2.32 to 0.83) | 0.345 | |
| 19.81 (3.90) | 19.50 (4.03)) | 19.00 (3.01) | 20.62 (2.90) | -1.01 (-2.59 to 0.56) | 0.203 | |
| 16.39 (2.94) | 16.26 (3.27) | 15.00 (2.96) | 15.45 (3.09) | 0.55 (-1.25 to 2.34) | 0.543 | |
| 16.11 (3.19) | 15.94 (3.45) | 14.68 (2.96) | 15.36 (3.08) | 0.24 (-1.57 to 2.06) | 0.225 | |
| 27.71 (5.87) | 29.56 (5.16) | 25.57 (5.63) | 25.64 (4.74) | 3.00 (0.46 to 5.54) | 0.021 | |
| 26.18 (6.43) | 28.00 (5.70) | 24.14 (6.31) | 24.93 (4.95) | 1.93 (-0.60 to 4.47) | 0.005 | |
Secondary outcome measures baseline and follow-up scores
| 51.55 (20.29) | 68.45 (12.02) | 49.15 (23.35) | 51.12 (21.19) | 17.38 (7.90 to 26.85) | 0.001 | |
| 10.50 (4.08) | 12.96 (2.83) | 10.63 (3.81) | 10.55 (3.920 | 1.996 (0.78 to 3.22) | 0.002 | |
| 53.77 (3.90) | 54.00 (4.78) | 53.39 (4.25) | 52.87 (3.40) | 0.76 (-1.73 to 3.26) | 0.539 | |
| 69.52 (9.84) | 70.30 (9.08) | 69.21 (12.32) | 69.94 (7.51) | 1.65 (-3.14 to 6.44) | 0.492 | |
| 7.21 (4.60) | 7.16 (4.33) | 6.36 (4.32) | 8.64 (4.99) | -1.47 (-3.31 to 0.37) | 0.116 | |
| 24.73 (5.34) | 24.21 (5.50) | 24.05 (5.71) | 24.31 (6.23) | -0.65 (-3.26 to 1.96) | 0.682 | |
| 18.15 (9.63) | 20.03 (8.25) | 16.83 (8.20) | 23.58 (9.37) | -3.77 (-8.07 to 0.54) | 0.085 | |